The RDD conference series impacts regulatory and scientific policies worldwide, and is recognized as one of the premier international meetings in this area. About 200 participants are expected to attend this international symposium devoted to issues surrounding nasal and pulmonary drug delivery.
The success of the Respiratory Drug Delivery (RDD) Conference series is founded on the selection of internationally renowned speakers, lively audience participation, and the financial support of organizations with a proven commitment to, and record of innovation in the field of inhalation aerosols.
Sponsoring RDD Asia 2024 is a great opportunity to demonstrate your organization's commitment to the advancement of high-quality science in the global inhalation community. Because RDD Online will enhance the visibility of your organization and personnel, the sooner you respond, the greater your benefit.